Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer
Michelle L. Baglia, Yong Cui, Tao Zheng, Gong Yang, Honglan Li, Mingrong You, Liling Xu, Harvey Murff, Yu-Tang Gao, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
Cancer Res Treat. 2019;51(2):538-546.   Published online 2018 Jul 2     DOI: https://doi.org/10.4143/crt.2017.591
Citations to this article as recorded by Crossref logo
Metformin protects against diabetes-induced heart injury and dunning prostate cancer model
BB Bayrak, P Koroglu, O Karabulut Bulan, R Yanardag
Human & Experimental Toxicology.2021; 40(2): 297.     CrossRef
Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, Mandy Juarez, Ariana Vargas-Castillo, Rafael Isaac Ponce-Toledo, Donna Lai, Sheng Hua, Armando R. Tovar, Nimbe Torres, Delia Perez-Montiel, Jose Diaz-Chavez, Alfonso Duenas-Gonzal
Scientific Reports.2021;[Epub]     CrossRef
Repurposing metformin for the treatment of gastrointestinal cancer
Ademar Dantas Cunha Júnior, Arinilda Campos Bragagnoli, Felipe Osório Costa, José Barreto Campello Carvalheira
World Journal of Gastroenterology.2021; 27(17): 1883.     CrossRef
Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study
Jiaojiao Zheng, Giola Santoni, Shao-Hua Xie, Jesper Lagergren
British Journal of Cancer.2021;[Epub]     CrossRef
The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
Chin-Hsiao Tseng
Biomolecules.2021; 11(7): 1022.     CrossRef
The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
Y. Shuai, C. Li, X. Zhou
Clinical and Translational Oncology.2020; 22(9): 1580.     CrossRef
The right place for metformin today
Guntram Schernthaner, Gerit-Holger Schernthaner
Diabetes Research and Clinical Practice.2020; 159: 107946.     CrossRef
Suppressive effects of metformin on colorectal adenoma incidence and malignant progression
Min Deng, Siqin Lei, Dongdong Huang, Hui Wang, Shuli Xia, Enping Xu, Yihua Wu, Honghe Zhang
Pathology - Research and Practice.2020; 216(2): 152775.     CrossRef

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend

Jing Zhang, Liping Wen, Quan Zhou, Kuifeng He, Lisong Teng
Cancer Management and Research.2020; Volume 12: 8545.     CrossRef
Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer? A Systematic Review and Meta-Analysis
Dong Peng, Yu-Xi Cheng, Wei Zhang
Diabetes Therapy.2020; 11(12): 2863.     CrossRef
Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
Cancer Epidemiology Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
Junichi Kato, Yohei Shirakami, Masahito Shimizu
Gastrointestinal Disorders.2019; 1(2): 273.     CrossRef
Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer
Yong Cui, Wanqing Wen, Tao Zheng, Honglan Li, Yu-Tang Gao, Hui Cai, Mingrong You, Jing Gao, Gong Yang, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
American Journal of Epidemiology.2019; 188(8): 1512.     CrossRef
Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type�2 diabetes mellitus and gastric cancer
Jinhui Liu, Li Yang
Oncology Letters.2019;[Epub]     CrossRef
A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer
Audrius Dulskas, Ausvydas Patasius, Donata Linkeviciute-Ulinskiene, Lina Zabuliene, Giedre Smailyte
Aging.2019; 11(17): 7197.     CrossRef